{
  "Conflict-Free": [
    {
      "id": 1,
      "title": "A Study in Back Pain Discomfort",
      "participants": "Back Pain Participants",
      "description": "This is a Phase 1, clinical trial for back pain that will be performed in San Francisco. This study will enroll a sufficient number of participants to see  any side effects realted to back pain medicine.",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "21 and older",
              "requirement_two": "Allergy Test Required",
              "requirement_three": "Back Pain",
              "requirement_four": "Gender Neutral"
            }
          ],
          "ineligible": [
            {
              "requirement_one": "Drug Allergies",
              "requirement_two": "No Backpain"
            }
          ]
        }
      ],
      "prerequisite": [
        { "requirement_one": "Must have Allergic Test Reaction test completed" }
      ],
      "detail": [
        {
          "_id": "CP10250110",
          "payout": "90",
          "status": "Recruiting",
          "study-type": "Observational",
          "start-date": "11/15/2021",
          "end-date": "02/15/2022",
          "last-updated": "10/03/2021"
        }
      ],
      "location": [
        {
          "address": "101 Van Ness Ave, San Francisco, CA 94109",
          "coordinates": [-122.4217866, 37.7763661]
        }
      ]
    },
    {
      "id": 2,
      "title": "Study of the Efficacy and Safety of Somatropin in Korean Participants With PWS",
      "participants": "Prader-Willi Syndrome Participants",
      "description": "The purpose of this trial is to study the safety of Somatropin for Koreans with PWS. ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "19 years and up",
              "requirement_two": "Aspergillosis",
              "requirement_three": "Gender Neutral",
              "requirement_four": "Mucormycosis"
            }
          ],
          "ineligible": [
            {
              "requirement_one": "Non Aspergillosis",
              "requirement_two": "Mucormycosis  "
            }
          ]
        }
      ],
      "prerequisite": [{ "requirement_one": "none" }],
      "detail": [
        {
          "_id": "CFT10250111",
          "payout": "80",
          "status": "Recruiting",
          "study-type": "Observational",
          "start-date": "11/10/2021",
          "end-date": "02/10/2022",
          "last-updated": "9/12/2021"
        }
      ],
      "location": [
        {
          "address": "2356 Sutter St, San Francisco, CA 94115",
          "coordinates": [-122.4415068, 37.7854709]
        }
      ]
    },
    {
      "id": 3,
      "title": "Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC",
      "participants": "mCRPC Participants",
      "description": "The purpose of this trial is to compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "18 years and up",
              "requirement_two": "Men",
              "requirement_three": "mCRPC"
            }
          ],
          "ineligible": [{ "requirement_one": "Non-men" }]
        }
      ],
      "prerequisite": [{ "requirement_one": "mCRPC drug test" }],
      "detail": [
        {
          "_id": "CFT10250112",
          "payout": "70",
          "status": "Recruiting",
          "study-type": "Interventional",
          "start-date": "12/15/2021",
          "end-date": "03/10/2022",
          "last-updated": "12/10/2021"
        }
      ],
      "location": [
        {
          "address": "101 Van Ness Ave, San Francisco, CA 94109",
          "coordinates": [-122.4217866, 37.7763661]
        }
      ]
    },
    {
      "id": 4,
      "title": "Safety and Efficacy of Lorbrena",
      "participants": "Non-small Cell Lung Cancer Participants",
      "description": "The purpose of this trial is to investigate the following matters under post-marketing use of Lorbrena in patients who received this drug Factors ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "18 years and up",
              "requirement_two": "Gender Neutral",
              "requirement_three": "Non-small Cell Lung Cancer"
            }
          ],
          "ineligible": [{ "requirement_one": "Lorbrena side effects" }]
        }
      ],
      "prerequisite": [{ "requirement_one": "Lorbrena drug test" }],
      "detail": [
        {
          "_id": "CFT10250113",
          "payout": "70",
          "status": "Recruiting",
          "study-type": "Interventional",
          "start-date": "12/22/2021",
          "end-date": "04/01/2022",
          "last-updated": "12/10/2021"
        }
      ],
      "location": [
        {
          "address": "2356 Sutter St, San Francisco, CA 94115",
          "coordinates": [-122.4415068, 37.7854709]
        }
      ]
    },
    {
      "id": 5,
      "title": "Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients ",
      "participants": "COVID-19 Participants",
      "description": "The purpose of this trial is  to be tested is whether or not there is a difference in time to sustained alleviation of all targeted COVID-19 signs and symptoms. ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "COVID-19 Positive",
              "requirement_two": "Gender Neutral",
              "requirement_three": "18+ years"
            }
          ],
          "ineligible": [{ "requirement_one": "COVID-19 Negative" }]
        }
      ],
      "prerequisite": [{ "requirement_one": "Lorbrena drug test" }],
      "detail": [
        {
          "_id": "CFT10250114",
          "payout": "50",
          "status": "Recruiting",
          "study-type": "Interventional",
          "start-date": "12/09/2021",
          "end-date": "05/01/2022",
          "last-updated": "12/12/2021"
        }
      ],
      "location": [
        {
          "address": "2356 Sutter St, San Francisco, CA 94115",
          "coordinates": [-122.4415068, 37.7854709]
        }
      ]
    },
    {
      "id": 6,
      "title": "Study of the Efficacy and Safety PF-06741086",
      "participants": "Hemophilia A, Hemophilia B Participants",
      "description": "The purpose of this trial is  to be tested is whether or not there is a difference in time to sustained alleviation of all targeted COVID-19 signs and symptoms. ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "Hemophilia A",
              "requirement_two": "Hemophilia B",
              "requirement_three": "Male",
              "requirement_four": "12-50 years"
            }
          ],
          "ineligible": [
            {
              "requirement_one": "Non-Hemophilia A",
              "requirement_two": "Non-Hemophilia B"
            }
          ]
        }
      ],
      "prerequisite": [
        {
          "requirement_one": "Severe Hemophilia A",
          "requirement_two": "Moderately Severe to Severe Hemophilia B"
        }
      ],
      "detail": [
        {
          "_id": "CFT10250115",
          "payout": "60",
          "status": "Recruiting",
          "study-type": "Interventional",
          "start-date": "12/09/2021",
          "end-date": "05/01/2022",
          "last-updated": "12/12/2021"
        }
      ],
      "location": [
        {
          "address": "101 Van Ness Ave, San Francisco, CA 94109",
          "coordinates": [-122.4217866, 37.7763661]
        }
      ]
    },
    {
      "id": 7,
      "title": "MenABCWY Noninferiority Study in Healthy Participants â‰¥10 to <26 Years of Age",
      "participants": "Meningococcal Vaccine ",
      "description": "The aim of this study is to determine the immunologic noninferiority of MenABCWY to licensed vaccines Trumenba and MenACWY-CRM (Menveo) by assessing the safety and immunogenicity of MenABCWY  ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "MenABCWY",
              "requirement_two": "MenACWY-CRM (Menveo)",
              "requirement_three": "Gender Neutral",
              "requirement_four": "10-25 years"
            }
          ],
          "ineligible": [
            {
              "requirement_one": "27+ years",
              "requirement_two": "Trumenba vacines allergic"
            }
          ]
        }
      ],
      "prerequisite": [
        {
          "requirement_one": " MenABCWY ",
          "requirement_two": "Trumenba allergic reaction result"
        }
      ],
      "detail": [
        {
          "_id": "CFT10250116",
          "payout": "50",
          "status": "Recruiting",
          "study-type": "Observational",
          "start-date": "12/09/2021",
          "end-date": "05/01/2022",
          "last-updated": "12/12/2021"
        }
      ],
      "location": [
        {
          "address": "101 Van Ness Ave, San Francisco, CA 94109",
          "coordinates": [-122.4217866, 37.7763661]
        }
      ]
    },
    {
      "id": 8,
      "title": "A Study of PF-07260437 in Advanced or Metastatic Solid Tumors",
      "participants": "Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms ",
      "description": "A study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of PF-07260437 ",
      "eligibility": [
        {
          "eligible": [
            {
              "requirement_one": "Neoplasms",
              "requirement_two": "Gender Neutral",
              "requirement_three": "Metastatic Solid Tumors",
              "requirement_four": "10-25 years"
            }
          ],
          "ineligible": [
            {
              "requirement_one": "Non-neoplasms",
              "requirement_two": "Non-Metastatic Solid Tumors"
            }
          ]
        }
      ],
      "prerequisite": [
        " Ovarian Neoplasms",
        "Endometrial Neoplasms",
        "Breast Neoplasms"
      ],
      "detail": [
        {
          "_id": "CFT10250117",
          "payout": "70",
          "status": "Recruiting",
          "study-type": "Interventional",
          "start-date": "12/01/2021",
          "end-date": "06/01/2022",
          "last-updated": "12/02/2021"
        }
      ],
      "location": [
        {
          "address": "101 Van Ness Ave, San Francisco, CA 94109",
          "coordinates": [-122.4217866, 37.7763661]
        }
      ]
    }
  ]
}
